WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis

Portfolio Overview

As of September 30, 2025

Asset Allocation

Equity: 89.07%Others: 10.93%

Market Cap

Small Cap: 46.56%Large Cap: 14.14%Mid Cap: 25.28%Equity: 3.09%

Number of stocks

54

Top 10 Holdings

91.86% of portfolio

Market Cap of Equity

Small Cap
46.5578%
Large Cap
14.1371%
Mid Cap
25.2826%
Equity
3.0899%

Companies Allocation of Equity

J.B. Chemicals & Pharmaceuticals Ltd13.87%
Sun Pharmaceuticals Industries Ltd13.62%
Fortis Healthcare Ltd13.37%
Cipla Ltd9.11%
Laurus Labs Ltd8.57%
Krishna Institute of Medical Sciences Ltd8.18%
Neuland Laboratories Ltd6.40%
Max Healthcare Institute Ltd Ordinary Shares6.37%
Lupin Ltd6.28%
Apollo Hospitals Enterprise Ltd6.10%

Sector Allocation of Equity

Healthcare84.51%
Basic Materials4.05%
Financial Services0.50%

SIP Amount

Monthly SIP Date

WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.